(Q57244704)

English

Co-prescribing of SSRIs and TCAs in Australia: how often does it occur and who is doing it?

article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Co-prescribing of SSRIs and TCAs in Australia: how often does it occur and who is doing it? (English)

0 references

0 references

Philip Mitchell

3

0 references

author name string

Peter McManus

series ordinal

1

0 references

Andrea Mant

series ordinal

2

0 references

Don Birkett

series ordinal

4

0 references

John Dudley

series ordinal

5

0 references

language of work or name

English

0 references

publication date

7 July 2008

0 references

published in

British Journal of Clinical Pharmacology

0 references

volume

51

0 references

issue

1

0 references

page(s)

93-98

0 references

cites work

Drug interactions of clinical significance with selective serotonin reuptake inhibitors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01319.X

retrieved

21 January 2018

Fatal toxicity of antidepressant drugs in overdose

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01319.X

retrieved

21 January 2018

Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01319.X

retrieved

21 January 2018

A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01319.X

retrieved

21 January 2018

Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01319.X

retrieved

21 January 2018

Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01319.X

retrieved

21 January 2018

Compliance with restrictions on the subsidized use of proton pump inhibitors in Australia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01319.X

retrieved

21 January 2018

Identifiers

DOI

10.1046/J.1365-2125.2001.01319.X

0 references

(Q57244704)

Co-prescribing of SSRIs and TCAs in Australia: how often does it occur and who is doing it?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)